|
|
|
|
|
|
| Ibraheem (Ibs) Mahmood is President and CEO of DrugDev, an innovative technology company that provides cloud-based solutions to help sponsors, CROs and investigators do more trials together. At the marcus evans Evolution Summit 2015, Ibs will discuss the impact of technology, collaboration and standards on clinical trial efficiency. |
NEW YORK, N.Y., May 6, 2015 - (ACN Newswire) - "Our mission at DrugDev is to help sponsors and CROs disrupt the clinical research process by providing access to innovative technology solutions and driving standards that improve efficiency throughout the industry," says Ibraheem (Ibs) Mahmood, President and CEO of DrugDev. "This will enable drug development companies to run more trials, thereby bringing more drugs to the patients who need them worldwide, for the same money. I am excited that so many pharmaceutical and CRO leaders are ready to come together as an industry to say 'Let's stop talking about it, and do it.'"
DrugDev is a service provider at the marcus evans Evolution Summit 2015, in Palm Beach, Florida, May 6-8.
- How could pharma and biotech improve trial efficiency and increase ROI?
The very short answer is by using technology well. The people who run clinical trials want to use modern, technology-powered processes. They want to leverage the same technologies they use in their personal lives to make clinical trials more efficient.
Until the last few years the clinical trials industry has been slow to adopt technology, but recently there has been increasing enthusiasm to share data and standardize on technology-driven processes.
With money running short and an unprecedented stockpile of exciting medicines waiting to be tested, pharma is looking to technology to help drive efficiency. This is not about adopting cutting-edge technology. It is about using proven software and processes that are already well embedded in other industries and will help us be more effective and efficient.
- What technologies can they better utilize?
There are proven technologies for every phase of clinical research.
Sponsors and CROs can use online registries to find investigators who are actively seeking new clinical trial opportunities and match investigators to protocols. For example, DrugDev is the third-party host of the Investigator Databank, a groundbreaking information sharing collaboration among Janssen, Lilly, Merck, Pfizer and Novartis. The Investigator Databank reduces the administrative burden for investigators and increases the visibility of qualified investigators to research sponsors. Sharing information allows for better matching of investigators and future protocols, and provides a benefit to both parties.
We are also working with TransCelerate to develop and host the Investigator Registry which will enable Member Companies to pool investigator data together into a centralized, cloud-based resource using a unique identifier called the DrugDev Golden Number. This will allow sponsors to create a single reliable source of matched and mastered global investigator data.
We have seen sponsors achieve tremendous ROI by using a cloud-based clinical trial optimization system - ours is called DrugDev TrialNetworks - to improve clinical operations quality and efficiency from startup through closeout with workflow tools, training and site engagement apps.
An automated payment solution such as DrugDev Payments [formerly CFS Clinical] can be used to ensure sites are paid accurately and on time - and therefore improve site satisfaction while saving time and significantly reducing costly overpayment errors.
Social media also can open up a trial to a much broader range of doctors. Why not create a network for doctors who can instantly find out what trials are being conducted anywhere in the world? Technology like this can reduce the time it takes to find a relevant investigator from months to days.
- A DrugDev survey recently showed that the majority of sites want to do more trials. What has proven to be a major obstacle?
Before the advent of technology-driven solutions, it was hard for doctors who wanted to participate in a trial to be made aware of an appropriate opportunity, and even harder for them to complete site feasibility assessments, recruit and engage patients, train and retrain staff, keep up with protocol changes, stay focused on the trial, manage documents and of course get paid.
Technology is changing the landscape. We are using systems to connect sponsors and CROs with investigators, and keeping them engaged and productive throughout from startup through closeout. By reducing complexity, time and cost, technology enables the industry to do more trials and bring more drugs to market for the patients who need them.
About the Evolution Summit 2015
The 8th Evolution Summit is the premium forum bringing clinical trial experts from leading drug development companies and solution providers together. The Summit offers an intimate environment for a focused discussion of key new drivers shaping drug development. Taking place at the Eau Palm Beach Resort & Spa, Palm Beach, Florida, May 6-8, 2015, the Summit includes presentations on improving trial performance, driving innovation, site selection and feasibility, and pinpointing recent trends.
For more information please send an email to press@marcusevanscy.com or visit the event website at www.evolutionsummit.com/IbraheemMahmoodInterview
marcus evans group - life sciences / pharma sector portal - www.marcusevans.com/reviews/sciences
The Pharma Network - marcus evans Summits group delivers peer-to-peer information on strategic matters, professional trends and breakthrough innovations.
- LinkedIn: www.linkedin.com/groups?gid=3529112&trk=myg_ugrp_ovr
- YouTube: www.youtube.com/MarcusEvansPharma
- Twitter: www.twitter.com/meSummitsPharma
- SlideShare: www.slideshare.net/MarcusEvansPharma
Please note that the Summit is a closed business event and the number of participants strictly limited.
About DrugDev
DrugDev is an innovative technology company which provides cloud-based solutions to help sponsors, CROs and investigators do more clinical trials together. Built around the largest global network of active opted-in investigators, DrugDev's unified solutions suite optimizes site selection and startup, investigator payments and clinical operations. DrugDev also serves as the trusted third-party host of the revolutionary Investigator Databank collaboration. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs rely on DrugDev technology to do more trials at www.drugdev.com.
Contact:
Sarin Kouyoumdjian-Gurunlian
Press Manager, marcus evans, Summits Division
Tel: +357 22 849 313
Email: press@marcusevanscy.com
Topic: Trade Show or Conference
Source: marcus evans Summits
Sectors: Daily Finance, Daily News, BioTech
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| marcus evans Summits |
| Jan 5, 2016 15:31 HKT/SGT |
|
How the Right Interior Design Can Lead to an Unforgettable Hotel Experience |
| Jan 5, 2016 14:53 HKT/SGT |
|
Why Hotels Need to Invest in Technology |
| Jan 5, 2016 14:15 HKT/SGT |
|
Why Defence Organisations Should Reconsider Their Talent Management Approach |
| Oct 23, 2015 03:00 HKT/SGT |
|
How to Distinguish the Right Emerging Markets to Invest in |
| Oct 22, 2015 21:20 HKT/SGT |
|
How to Design a Solid Privacy and Data Protection Programme |
| Oct 22, 2015 21:00 HKT/SGT |
|
The Wellness Model: A Business Strategy to Reduce Healthcare Costs |
| Oct 17, 2015 02:20 HKT/SGT |
|
The Changing Dynamics of the Oil Market |
| Oct 17, 2015 02:10 HKT/SGT |
|
How China's Slowdown Affects Global Investors |
| Oct 17, 2015 02:00 HKT/SGT |
|
How to Use Globalisation as a Marketing Tool |
| Sept 30, 2015 07:30 HKT/SGT |
|
The Need for Holistic Revenue Cycle Management Models |
| More news >> |
 |
|
|
|
